These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date, and reported results 2005-000840-10 Open Label Phase II Multicenter Study for the Evaluation of Pharmacokinetics of VENBIG (Human Immunoglobulin anti-Hepatitis B for Intravenous Use) and IMMUNOHBS (Human Immunoglobulin anti Hepatitis B ... bad-data
Completed, but no date, and reported results 2005-001136-76 Double blind Randomized Controlled trial of prolonged treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)with high dose intravenous immunoglobulins (IVIg) or intravenous meti... bad-data
Completed, but no date, and reported results 2005-006186-14 Open Label Phase II Evaluation of Pharmacokinetics, Efficacy, and Safety of Kedrion Human Plasma-derived Antihaemophilic Double Virus inactivated and Nanofiltered Factor IX Administered to Previously ... bad-data
Completed, but no date, and reported results 2007-005583-27 A multi-center, randomized, prospective, controlled open-label Phase II/III study to assess the safety and sealing efficacy of Kedrion Fibrin Sealant in patients eligible for anatomical pulmonary rese... bad-data
Completed, but no date, and reported results 2009-011603-23 Evaluation of Haemostatic Efficacy, Tolerability and Safety of Kedrion Fibrin Sealant in patients undergoing major or minor Liver Surgery. Multicenter, Controlled, Open Label Randomised Phase II/III... bad-data
Completed, but no date, and reported results Terminated 2010-020167-20 Pharmacokinetics, efficacy, tolerability and safety evaluation of the therapy with subcutaneous immunoglobulin in the treatment of hypo or agammaglobulinaemic patients. Open label phase II/III study bad-data
Ongoing 2010-021473-36 Efficacy and Safety evaluation of Kedrion Human Hepatitis B Immunoglobulin for intramuscular use in the prevention of hepatitis B in the newborns of Hepatitis B Virus carrier-mothers: multi-centre, ... not-yet-due
Completed, but no date, and reported results 2010-023991-15 Efficay and Safety Evaluation of Kedrion Fibrin Sealant, in middle ear microsurgery. Monocenter, controlled, single blind, randomised, two parallel arms, phase II/III study Valutazione dell’efficac... bad-data
Completed, but no date, and reported results 2012-001340-21 A Historically-Controlled Phase II/III study to Evaluate Efficacy and Safety of Kedrion Human Plasminogen Eye Drop Preparation in Patients Diagnosed with Ligneous Conjunctivitis Studio di Fase II/I... bad-data
Completed, but no date Terminated 2012-002328-34 Efficacy and safety evaluation of Kedrion Fibrin Sealant as an adjuvant for the control of hemostasis in pediatric patients undergoing abdominal or orthopedic surgery. Multicenter, randomized, control... bad-data
Completed, but no date Terminated 2012-002342-21 Valutazione dell’Efficacia e della Sicurezza della Colla di Fibrina Kedrion come coadiuvante per il controllo dell’emostasi in pazienti pediatrici sottoposti ad interventi di cardiochirurgia a cuore a... bad-data
Reported results 2013-000961-36 Tolerability and safety evaluation of the administration of Ig VENA at high infusion rates. Open label phase III study. Bewertung der Verträglichkeit und Sicherheit der Verabreichung von Ig VENA be... 2015-03-31 due-trials
Ongoing 2020-001496-32 A Phase III, Open-label, Prospective, Multicenter Study to Assess Efficacy, Safety, and Pharmacokinetics of Kedrion Intravenous Human Normal Immunoglobulin (IVIg) 10% in Pediatric Patients Affected by... not-yet-due
Ongoing 2020-003570-49 Phase III, Open-label, Uncontrolled, Multicenter Study to Assess Efficacy, Pharmacokinetics and Safety of IMMUNORHO in the Prevention of RhD Isoimmunization in Rh(D) negative Women Pregnant with Rh(D)... not-yet-due